Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1999;24(5):463-4.

[Clinical observation on ondansetron in preventing nausea and vomiting after cholecystectomy under abdominoscope]

[Article in Chinese]
Affiliations
  • PMID: 12080685
Clinical Trial

[Clinical observation on ondansetron in preventing nausea and vomiting after cholecystectomy under abdominoscope]

[Article in Chinese]
Y Li et al. Hunan Yi Ke Da Xue Xue Bao. 1999.

Abstract

Objective: To evaluate the prophylactic effect of ondansetron on postoperative nausea and vomiting (PONV) of cholecystectomy under abdominoscope.

Methods: Sixty patients, scheduled for selective cholecystectomy under abdominoscope, were randomly and double-blindly allocated to receive an intravenous bolus of either 0.9% NS 10 ml(Group placebo, n = 30) or 8 mg of ondansetron in 10 ml solution(Group ondansetron, n = 30), respectively.

Results: The incidences of nausea and vomiting in ondansetron group(33.3% and 26.7%) were significantly lower than those in placebo group(73.3% and 66.7%) (P < 0.05). Administration of ondansetron had no obvious effect on the mean arterial pressure, SpO2, and respiratory frequency.

Conclusion: Ondansetron can be used effectively and safely to prevent PONV in cholecystectomy patients under abdominoscope.

PubMed Disclaimer

MeSH terms

LinkOut - more resources